BRN Discussion Ongoing

[Diogenese]

Partnerships are great. Building the eco system is great. Being in universities is great. Having solid patent protection is great.
I like and endorse all those things and they make sense to me.
If we were living in the Star Trek universe, they would all probably be sufficient and we could just get on exploring the universe.

But in this one, where small investors back companies with an understanding that they will be compensated for the use of their capital and the risk undertaken, eventually the Company must be able to at least stand on it's own feet and that involves bringing in more revenue than it takes to fund the operation.
We are now well over 3 years into Sean's 5 year plan.
It's time to see us making some progress towards commercial adoption.
ISL and RTX are nice nibbles and will hopefully prove our worth and allow us further traction and adoption within these companies.
I'm also happy for us to be continuing our R&D and expanding our product range, particularly in light of customer feedback.

But the fact remains that Sean was bought onboard to commercialise us and our product and that has been the promise and supposedly the emphasis for at least the last two years.
I'd appreciate some straight talk from Sean about where we are at commercially.
I'm not asking him to predict the future, but an honest disclosure of our progress in relation to his plan thus far, would go some way towards restoring his credibility, which, in my eyes anyway, is wearing thin.

Hi Hoppy,

The sad fact is that the company gets $0.00 from shares bought on market. IPO aside, it is only when new shares are offered that the company gets any money from share sales.

I'd like to see a system where the company gets a small percent of each on market sale. That way, bot trading and shorting would provide some little benefit the company.

It's good to get a couple of radar partnerships in a couple of days. Tony Lewis linked the ILS partnership with TENNs. I think that the Raytheon/AFRL micro-doppler project will also employ TENNs.

Funny thing, the SBIR site has a short memory: (Maybe they are using Signal.)

https://www.islinc.com/national-security
,,,
ISL has an impressive record of transitioning advanced technologies to the field. In the last few years alone, ISL has been awarded three (3) Phase III SBIR contracts, and has been featured twice as an SBIR Success Story (see for example https://www.sbir.gov/node/1526807).

https://www.sbir.gov/node/1526807
...
The requested page could not be found.

Interestingly Joe Guerci is a pre-Trump-appointed Special Government Employee:

https://www.linkedin.com/in/joe-guerci-505aa26/

Special Government Employee (SGE)
US Army · Part-time Nov 2024 - Present · 6 mos

• • Consultant to Army Science Board

 

[Smoothsailing]

What time is Nintendo releasing their specifications today anyone please ?

 

[Schwale]

What time is Nintendo releasing their specifications today anyone please ?

NINTENDO SWITCH 2 NINTENDO DIRECT TIMES AUSTRALIA​

The Nintendo Direct for the Nintendo Switch 2 will be taking place on Thursday April 3rd (Melbourne/Sydney) or Wednesday, April 2nd (rest of Australia). The Direct will last 60 minutes in length

• Thursday 00:00 AEDT (Melbourne/Sydney/Hobart/Canberra)
• Wednesday 11:30pm ACDT (Adelaide)
• Wednesday 11:00pm AEST (Brisbane)
• Wednesday 10:30pm ACST (Darwin)
• Wednesday 9:00pm AWST (Perth)

 

[Bravo]

#israeli #technology #founders | Avraham Hermon

In this picture with Ilay Marom, COO of NaNose Medical, we are holding in our hands a machine which can detect common, life-threatening diseases using a quick…

www.linkedin.com

View attachment 81092

I just listed to to this podcast, which was recorded two days ago with Ilay Marom from Nanose Medical.

In the podcast Ilay discusses Nanose's non-invasive hand-held breath test which can provide early detection of Metabolic dysfunction-associated steatotic liver disease (MASLD). He talks about how it can do via a sensor array using a pattern recognition algorithm. He believes the device will be a "game-changer" because it can be used everywhere.

He talks about the how the technology was invented over a decade ago at Technion Israel Institute of Technology by Prof. Hossam Haick.

When asked to explain the technology he talked a bit about nano particles but he said he couldn't talk about what was different about their sensors because part of it is confidential. He mentioned that there are 7 patents for the technology held by Technion, 1 patent is Nanose own and there another 4 patents pending.

Ilay repeated that the way they produce their sensor is not patented, that instead it's a "trade secret". He describes it being the secret sauce, like the Coca-Cola recipe.

Nanose are hoping to bring this device to the market by 2026 to detect MASLD (fatty liver disease) and then expect to be able to bring another variation to market to detect lung disease by 2027.

Asked about their 5 year plan, Ilay said he hopes the device will be in every clinic and that it will save millions of lives and billions of dollars.

If I'm not mistaken, I recall that a few years ago Nanose had some sort of issue with the manufacturing of the sensors that meant they couldn't achieve consistent results, so they must have somehow overcome this issue, which is great new.

I also remember someone from this forum saying they had spoken to PVDM after the 2022 AGM and Peter had apparently confirmed that the problem was only with the sensor and not with our technology. I don't know if anyone else has more information to add about whether this is correct?

For convenience I've also attached Rich Wawrzyniak's 2021 Nanose/BrainChip Blog. It shows a list of diseases detected with the Nanose device. Curiously MASLD isn't one of them.

The above Semico article is also still displayed on our website, if that means anything.

 

[Smoothsailing]

NINTENDO SWITCH 2 NINTENDO DIRECT TIMES AUSTRALIA​

The Nintendo Direct for the Nintendo Switch 2 will be taking place on Thursday April 3rd (Melbourne/Sydney) or Wednesday, April 2nd (rest of Australia). The Direct will last 60 minutes in length

• Thursday 00:00 AEDT (Melbourne/Sydney/Hobart/Canberra)
• Wednesday 11:30pm ACDT (Adelaide)
• Wednesday 11:00pm AEST (Brisbane)
• Wednesday 10:30pm ACST (Darwin)
• Wednesday 9:00pm AWST (Perth)

Thanks mate

 

[manny100]

Hi Hoppy,

The sad fact is that the company gets $0.00 from shares bought on market. IPO aside, it is only when new shares are offered that the company gets any money from share sales.

I'd like to see a system where the company gets a small percent of each on market sale. That way, bot trading and shorting would provide some little benefit the company.

It's good to get a couple of radar partnerships in a couple of days. Tony Lewis linked the ILS partnership with TENNs. I think that the Raytheon/AFRL micro-doppler project will also employ TENNs.

Funny thing, the SBIR site has a short memory: (Maybe they are using Signal.)

https://www.islinc.com/national-security
,,,
ISL has an impressive record of transitioning advanced technologies to the field. In the last few years alone, ISL has been awarded three (3) Phase III SBIR contracts, and has been featured twice as an SBIR Success Story (see for example https://www.sbir.gov/node/1526807).

https://www.sbir.gov/node/1526807
...
The requested page could not be found.

Interestingly Joe Guerci is a pre-Trump-appointed Special Government Employee:

https://www.linkedin.com/in/joe-guerci-505aa26/

Special Government Employee (SGE)
US Army · Part-time Nov 2024 - Present · 6 mos

• • Consultant to Army Science Board

Even a minimal order amount would stop the ridiculous minimal share transactions. No many genuine participants would buy/sell less than $???
Bot order systems are clearly designed to take money from retailers.

 

[manny100]

I just listed to to this podcast, which was recorded two days ago with Ilay Marom from Nanose Medical.

In the podcast Ilay discusses Nanose's non-invasive hand-held breath test which can provide early detection of Metabolic dysfunction-associated steatotic liver disease (MASLD). He talks about how it can do via a sensor array using a pattern recognition algorithm. He believes the device will be a "game-changer" because it can be used everywhere.

He talks about the how the technology was invented over a decade ago at Technion Israel Institute of Technology by Prof. Hossam Haick.

When asked to explain the technology he talked a bit about nano particles but he said he couldn't talk about what was different about their sensors because part of it is confidential. He mentioned that there are 7 patents for the technology held by Technion, 1 patent is Nanose own and there another 4 patents pending.

Ilay repeated that the way they produce their sensor is not patented, that instead it's a "trade secret". He describes it being the secret sauce, like the Coca-Cola recipe.

Nanose are hoping to bring this device to the market by 2026 to detect MASLD (fatty liver disease) and then expect to be able to bring another variation to market to detect lung disease by 2027.

Asked about their 5 year plan, Ilay said he hopes the device will be in every clinic and that it will save millions of lives and billions of dollars.

If I'm not mistaken, I recall that a few years ago Nanose had some sort of issue with the manufacturing of the sensors that meant they couldn't achieve consistent results, so they must have somehow overcome this issue, which is great new.

I also remember someone from this forum saying they had spoken to PVDM after the 2022 AGM and Peter had apparently confirmed that the problem was only with the sensor and not with our technology. I don't know if anyone else has more information to add about whether this is correct?

For convenience I've also attached Rich Wawrzyniak's 2021 Nanose/BrainChip Blog. It shows a list of diseases detected with the Nanose device. Curiously MASLD isn't one of them.

View attachment 81097



The above Semico article is also still displayed on our website, if that means anything.


View attachment 81098

Great article, thanks, looks like many diseases are detectable but i guess still waiting on Health approvals.

 

[Tezza]

QSuper won’t allow.

Cbus also won't do it

 

[CHIPS]

Partnerships are great. Building the eco system is great. Being in universities is great. Having solid patent protection is great.
I like and endorse all those things and they make sense to me.
If we were living in the Star Trek universe, they would all probably be sufficient and we could just get on exploring the universe.

But in this one, where small investors back companies with an understanding that they will be compensated for the use of their capital and the risk undertaken, eventually the Company must be able to at least stand on it's own feet and that involves bringing in more revenue than it takes to fund the operation.
We are now well over 3 years into Sean's 5 year plan.
It's time to see us making some progress towards commercial adoption.
ISL and RTX are nice nibbles and will hopefully prove our worth and allow us further traction and adoption within these companies.
I'm also happy for us to be continuing our R&D and expanding our product range, particularly in light of customer feedback.

But the fact remains that Sean was bought onboard to commercialise us and our product and that has been the promise and supposedly the emphasis for at least the last two years.
I'd appreciate some straight talk from Sean about where we are at commercially.
I'm not asking him to predict the future, but an honest disclosure of our progress in relation to his plan thus far, would go some way towards restoring his credibility, which, in my eyes anyway, is wearing thin.

Who is getting a guarantee at the stock market to make a profit and expects this? It is always a risk and I often lost money in the past because companies were sold or taken out of business. Nobody asked me whether I had been in the green when this happened and nobody compensated me for it. If one cannot live with this, one should not buy stocks.

 

[Diogenese]

Great article, thanks, looks like many diseases are detectable but i guess still waiting on Health approvals.

Hi Bravo,

Yes. It's taken Nanose a while to sort out the nanotech manufacture. Back then, the test was run on Akida with stored Nanose results, but they mentioned that they had to cut a significant number of results before the test because they were erroneous. So I guess their "secret sauce" improvements have improved consistency and accuracy.

 

[CHIPS]

Meine Güte..........

FWIW..........
View attachment 81058

HAPPY AS LARRY - STILL BUYING

Which page did you get this from? Link please.

 

[cosors]

Sorry for the bold and layout.

"Apr 2, 2025 2:00 AM Eastern Daylight Time

Frontgrade Gaisler Launches New GRAIN Line and Wins SNSA Contract to Commercialize First Energy-Efficient Neuromorphic AI for Space Applications​

View attachment 81100 ​

​

GOTHENBURG, Sweden--(BUSINESS WIRE)--The Swedish National Space Agency (SNSA) has awarded Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, a contract to commercialize the first neuromorphic System on Chip (SoC) device for space applications. Already in development at Frontgrade Gaisler, the device is part of the company’s new GRAIN (Gaisler Research Artificial Intelligence NOEL-V) product line.​

“GRAIN is an exciting new pursuit for Gaisler because we are well positioned to enable new capabilities for real-time data processing, autonomous navigation, Earth observation, and object detection and tracking,” Sandi Habinc, GM of Frontgrade Gaisler.

Share​

​

The first GRAIN device that Frontgrade Gaisler will premiere – the Gr801 SoC – integrates Akida™ neuromorphic technology from BrainChip, the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI. The GR801 combines Gaisler’s NOEL-V RISC-V processor and the Akida neuromorphic AI processor into a single integrated circuit to enable energy-efficient AI applications in the space environment. Sweden’s Royal Institute of Technology (KTH) is contributing to this development by designing a demonstration application that uses a neuromorphic sensor directly connected to Gaisler’s new GR801 device.​

​

Frontgrade Gaisler is designing the entire GRAIN product line to enable more advanced and autonomous space missions, and to enhance the space industry's capabilities in energy-efficient AI. The GR801 SoC will support both commercial and institutional space missions, enabling new applications and meeting strict power and weight constraints.​

​

“Our latest innovation opens new avenues and complements our existing range of proven and reliable processing products,” said Sandi Habinc, General Manager at Frontgrade Gaisler. “GRAIN is an exciting new pursuit for Gaisler because we are well positioned to enable new capabilities for real-time data processing, autonomous navigation, Earth observation, and object detection and tracking.”​

​

Share​

---

​

​

Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, has launched its new Gaisler Research Artificial Intelligence NOEL-V (GRAIN) product line. The first GRAIN device to premiere – the Gr801 SoC – integrates Akida™ neuromorphic technology from BrainChip, the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI.​

​

“Our continued collaboration with Frontgrade Gaisler to incorporate Akida IP into space SoCs showcases the importance of having environmentally hardened solutions, already proven to perform in the most extreme conditions,” said Sean Hehir, CEO of BrainChip. “We have worked hard to ensure our neuromorphic technology can meet the low-energy, low-latency, high-performance needs of GRAIN and other space-based devices in order to provide AI at – and beyond – the edge.”​

Frontgrade Gaisler announced its new GRAIN product line at the second RISC-V in Space Workshop 2025, in Gothenburg, Sweden. The event focuses on how RISC-V technology is being leveraged in space systems, ranging from satellites to deep space missions. Learn more about the GRAIN product line at gaisler.com/grain​

​

..."​

Frontgrade Gaisler Launches New GRAIN Line and Wins SNSA Contract to Commercialize First Energy-Efficient Neuromorphic AI for Space Applications

The Swedish National Space Agency (SNSA) has awarded Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, a contr...

www.businesswire.com

 

[Space Cadet]

Hi SC,
I had a similar problem a while back. I found that I had inadvertently put the thread's originator, Techgirl, on ignore. I reversed that and it became visible again. Good luck!

Samod

You are a legend. By the way you are correct it was by mistake. Who would intentionally ignore her. Thanks mate.

SC

 

[Frangipani]

Today and tomorrow, BrainChip is in Gothenburg at the RISC-V in Space… | Alf Kuchenbuch

Today and tomorrow, BrainChip is in Gothenburg at the RISC-V in Space Congress, hosted by European Space Agency - ESA and Frontgrade Gaisler. Do drop by and…

www.linkedin.com

Kenneth Östberg will be presenting at the RISC-V in Space. Do not miss his… | Frontgrade Gaisler

Kenneth Östberg will be presenting at the RISC-V in Space. Do not miss his poster presentation! GRAIN – Radiation-Tolerant Edge AI 📅 Date: 3rd April 🕒 Time: 16:00-17:30

www.linkedin.com

 

[HopalongPetrovski]

Hi Hoppy,

The sad fact is that the company gets $0.00 from shares bought on market. IPO aside, it is only when new shares are offered that the company gets any money from share sales.

I'd like to see a system where the company gets a small percent of each on market sale. That way, bot trading and shorting would provide some little benefit the company.

It's good to get a couple of radar partnerships in a couple of days. Tony Lewis linked the ILS partnership with TENNs. I think that the Raytheon/AFRL micro-doppler project will also employ TENNs.

Funny thing, the SBIR site has a short memory: (Maybe they are using Signal.)

https://www.islinc.com/national-security
,,,
ISL has an impressive record of transitioning advanced technologies to the field. In the last few years alone, ISL has been awarded three (3) Phase III SBIR contracts, and has been featured twice as an SBIR Success Story (see for example https://www.sbir.gov/node/1526807).

https://www.sbir.gov/node/1526807
...
The requested page could not be found.

Interestingly Joe Guerci is a pre-Trump-appointed Special Government Employee:

https://www.linkedin.com/in/joe-guerci-505aa26/

Special Government Employee (SGE)
US Army · Part-time Nov 2024 - Present · 6 mos

• • Consultant to Army Science Board

Hi Dodgy.
You're right of course and I have happily bought direct on previous occasions and was delighted to know my money was primarily going straight into BrainChip's coffers.

Do you know if the system where the company traded gets a portion or tariff on each transaction as you outlined is in practice anywhere?
Seems a great idea to me also.
I guess the administration cost of it could be quite high, but on a large scale the bots would amortise it?
Probably unlikely the BEOT would ever allow it.
They own the game and why would they want to see it changed in any way, out of their favour.

And yes, the wins are welcome, but it just seems very itty bitty.
To continue to exist we need to become commercial and that's what I have been told (by Sean and Antonio and Ken and anyone else I have spoken too) has been high on the company's agenda for at least the last two full years.

I'm not saying "nothing" has occurred in this regard, but as far as revenue and commercial viability of the company is concerned, it's been pretty uninspiring.
And the lower our share price is pushed the more the necessary fund raising to keep the company going costs, and the greater the dilutionary effect it has on existing holdings and you and I, the holders.

We have been asked to buy in on Seans 5 year plan, basically sight unseen.
That's sort of fair enough, I guess.
He doesn't want to telegraph his moves to the competition.
I get that.
But given the progress to date, and considering the proposed re domicile, I'm personally over the glad handing and hearty knowing smiles and would like some honest and sincere information regarding just where exactly we are at, in regards to the plan.
Are we on track and on schedule?
What's going right and what's going wrong and what are they doing to fix it, or speed it up, or are significant results expected sooner or later than the proposed magic 5 years?
Sorry to bitch and moan everyone.
I know none of you have the answers to these questions.
I'll shut up for a while.
GLTAH

 

[Pom down under]

I just listed to to this podcast, which was recorded two days ago with Ilay Marom from Nanose Medical.

In the podcast Ilay discusses Nanose's non-invasive hand-held breath test which can provide early detection of Metabolic dysfunction-associated steatotic liver disease (MASLD). He talks about how it can do via a sensor array using a pattern recognition algorithm. He believes the device will be a "game-changer" because it can be used everywhere.

He talks about the how the technology was invented over a decade ago at Technion Israel Institute of Technology by Prof. Hossam Haick.

When asked to explain the technology he talked a bit about nano particles but he said he couldn't talk about what was different about their sensors because part of it is confidential. He mentioned that there are 7 patents for the technology held by Technion, 1 patent is Nanose own and there another 4 patents pending.

Ilay repeated that the way they produce their sensor is not patented, that instead it's a "trade secret". He describes it being the secret sauce, like the Coca-Cola recipe.

Nanose are hoping to bring this device to the market by 2026 to detect MASLD (fatty liver disease) and then expect to be able to bring another variation to market to detect lung disease by 2027.

Asked about their 5 year plan, Ilay said he hopes the device will be in every clinic and that it will save millions of lives and billions of dollars.

If I'm not mistaken, I recall that a few years ago Nanose had some sort of issue with the manufacturing of the sensors that meant they couldn't achieve consistent results, so they must have somehow overcome this issue, which is great new.

I also remember someone from this forum saying they had spoken to PVDM after the 2022 AGM and Peter had apparently confirmed that the problem was only with the sensor and not with our technology. I don't know if anyone else has more information to add about whether this is correct?

For convenience I've also attached Rich Wawrzyniak's 2021 Nanose/BrainChip Blog. It shows a list of diseases detected with the Nanose device. Curiously MASLD isn't one of them.

View attachment 81097



The above Semico article is also still displayed on our website, if that means anything.


View attachment 81098

And it’s been 4 years since the original application mentioning BRAINCHIP was submitted. I guess medical trials take a lot of time

US20230152319A1 - Device and method for rapid detection of viruses - Google Patents

The invention proposes an approach utilizing novel and artificially intelligent hybrid sensor arrays with multiplexed detection capabilities for disease-specific biomarkers from the exhaled breath of a subject. The technology provides a rapid and highly accurate diagnosis in various COVID-19...

patents.google.com

 

[HopalongPetrovski]

Who is getting a guarantee at the stock market to make a profit and expects this? It is always a risk and I often lost money in the past because companies were sold or taken out of business. Nobody asked me whether I had been in the green when this happened and nobody compensated me for it. If one cannot live with this, one should not buy stocks.

Yes, I wrote that clumsily. I meant to say that investors buy in, in the expectation of doing well. Of course there are no guarantees.

 

[Frangipani]

Sorry for the bold and layout.

"Apr 2, 2025 2:00 AM Eastern Daylight Time

Frontgrade Gaisler Launches New GRAIN Line and Wins SNSA Contract to Commercialize First Energy-Efficient Neuromorphic AI for Space Applications​

View attachment 81100 ​

GOTHENBURG, Sweden--(BUSINESS WIRE)--The Swedish National Space Agency (SNSA) has awarded Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, a contract to commercialize the first neuromorphic System on Chip (SoC) device for space applications. Already in development at Frontgrade Gaisler, the device is part of the company’s new GRAIN (Gaisler Research Artificial Intelligence NOEL-V) product line.​

​

“GRAIN is an exciting new pursuit for Gaisler because we are well positioned to enable new capabilities for real-time data processing, autonomous navigation, Earth observation, and object detection and tracking,” Sandi Habinc, GM of Frontgrade Gaisler.​

​

Share​

---

​

​

Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, has launched its new Gaisler Research Artificial Intelligence NOEL-V (GRAIN) product line. The first GRAIN device to premiere – the Gr801 SoC – integrates Akida™ neuromorphic technology from BrainChip, the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI.​

​

• 
  

GOTHENBURG, Sweden--(BUSINESS WIRE)--The Swedish National Space Agency (SNSA) has awarded Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, a contract to commercialize the first neuromorphic System on Chip (SoC) device for space applications. Already in development at Frontgrade Gaisler, the device is part of the company’s new GRAIN (Gaisler Research Artificial Intelligence NOEL-V) product line.​

​

​

Share​

​

The first GRAIN device that Frontgrade Gaisler will premiere – the Gr801 SoC – integrates Akida™ neuromorphic technology from BrainChip, the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI. The GR801 combines Gaisler’s NOEL-V RISC-V processor and the Akida neuromorphic AI processor into a single integrated circuit to enable energy-efficient AI applications in the space environment. Sweden’s Royal Institute of Technology (KTH) is contributing to this development by designing a demonstration application that uses a neuromorphic sensor directly connected to Gaisler’s new GR801 device.​

​

Frontgrade Gaisler is designing the entire GRAIN product line to enable more advanced and autonomous space missions, and to enhance the space industry's capabilities in energy-efficient AI. The GR801 SoC will support both commercial and institutional space missions, enabling new applications and meeting strict power and weight constraints.​

​

“Our latest innovation opens new avenues and complements our existing range of proven and reliable processing products,” said Sandi Habinc, General Manager at Frontgrade Gaisler. “GRAIN is an exciting new pursuit for Gaisler because we are well positioned to enable new capabilities for real-time data processing, autonomous navigation, Earth observation, and object detection and tracking.”​

​

Share​

---

​

​

Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, has launched its new Gaisler Research Artificial Intelligence NOEL-V (GRAIN) product line. The first GRAIN device to premiere – the Gr801 SoC – integrates Akida™ neuromorphic technology from BrainChip, the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI.​

​

• 
  

GOTHENBURG, Sweden--(BUSINESS WIRE)--The Swedish National Space Agency (SNSA) has awarded Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, a contract to commercialize the first neuromorphic System on Chip (SoC) device for space applications. Already in development at Frontgrade Gaisler, the device is part of the company’s new GRAIN (Gaisler Research Artificial Intelligence NOEL-V) product line.​

​

​

Share​

​

The first GRAIN device that Frontgrade Gaisler will premiere – the Gr801 SoC – integrates Akida™ neuromorphic technology from BrainChip, the world’s first commercial producer of ultra-low power, fully digital, event-based, neuromorphic AI. The GR801 combines Gaisler’s NOEL-V RISC-V processor and the Akida neuromorphic AI processor into a single integrated circuit to enable energy-efficient AI applications in the space environment.​

Sweden’s Royal Institute of Technology (KTH) is contributing to this development by designing a demonstration application that uses a neuromorphic sensor directly connected to Gaisler’s new GR801 device.​

Frontgrade Gaisler is designing the entire GRAIN product line to enable more advanced and autonomous space missions, and to enhance the space industry's capabilities in energy-efficient AI. The GR801 SoC will support both commercial and institutional space missions, enabling new applications and meeting strict power and weight constraints.​

“Our latest innovation opens new avenues and complements our existing range of proven and reliable processing products,” said Sandi Habinc, General Manager at Frontgrade Gaisler. “GRAIN is an exciting new pursuit for Gaisler because we are well positioned to enable new capabilities for real-time data processing, autonomous navigation, Earth observation, and object detection and tracking.”​

“Our continued collaboration with Frontgrade Gaisler to incorporate Akida IP into space SoCs showcases the importance of having environmentally hardened solutions, already proven to perform in the most extreme conditions,” said Sean Hehir, CEO of BrainChip. “We have worked hard to ensure our neuromorphic technology can meet the low-energy, low-latency, high-performance needs of GRAIN and other space-based devices in order to provide AI at – and beyond – the edge.”​

Frontgrade Gaisler announced its new GRAIN product line at the second RISC-V in Space Workshop 2025, in Gothenburg, Sweden. The event focuses on how RISC-V technology is being leveraged in space systems, ranging from satellites to deep space missions. Learn more about the GRAIN product line at gaisler.com/grain​

​

..."​

Frontgrade Gaisler Launches New GRAIN Line and Wins SNSA Contract to Commercialize First Energy-Efficient Neuromorphic AI for Space Applications

The Swedish National Space Agency (SNSA) has awarded Frontgrade Gaisler, a leading provider of radiation-hardened microprocessors for space missions, a contr...

www.businesswire.com

So it’s not going to be the GR765, then, but a completely new SoC, the GR801.

As predicted, Jörg Conradt’s lab at KTH Stockholm will be collaborating:
He better practice spelling and saying “Akida” correctly ASAP!

https://thestockexchange.com.au/threads/brn-discussion-ongoing.1/post-449511

 

[TheDrooben]

Which page did you get this from? Link please.

Via Commsec.......anyone who is with them can confirm it

 

[yogi]

Overview​

This page describes a running development and no guarantees can be given concerning future product availability. All information on this page is subject to change without notice. Please click this link to sign up to receive notifications about product and documentation updates.
The GRAIN architecture consists of a neuromorphic processing engine (Brainchip AkidaTM 1.0), a single-core RISC-V RV64GC processor (NOEL-V) for system management, and several digital interfaces.
GRAIN is a reliable computing platform for AI applications such as image recognition, autonomous navigation, and data analysis. The neuromorphic engine provides fast and energy-efficient inference, enabling fast on-board decisions.
‍

Software​

Block diagram​

Detailed features​

NOEL-V RISC-V Processor

• General-purpose RISC-V processor (RV64GC)
• High-performance processing for traditional computing tasks
• System management and configuration of the neuromorphic engine

AkidaTM neuromorphic processing accelerator

• ‍‍Akida provides acceleration of AI models using event-based computing to minimize power consumption.
• Eight neural processing nodes connected in a mesh network
• Each node consisting of four convolutional or fully connected engines
• Each node supports 128 4x4 MACs, for total of 1024 MACs/clock
• Hardware support for 1, 2, or 4-bit hybrid quantized weights
• Multi-Pass Processing enables execution of large neural networks

Interfaces

• ‍‍‍‍PCIe Gen 3 x4 port with capability to act both as a root port and as an endpoint
• 10/100/1000Mbit Ethernet interface
• 200Mbit/s SpaceWire port
• SPI,I2C and UART low speed interfaces.